IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Diagnosing Respiratory Disease in Children Using Cough Sounds (SMARTCOUGH-C)
This study is currently recruiting participants.
Verified April 2017 by ResApp Health Limited
Sponsor:
ResApp Health Limited
Collaborators:
Massachusetts General Hospital
The Cleveland Clinic
Texas Children's Hospital
Information provided by (Responsible Party):
ResApp Health Limited
ClinicalTrials.gov Identifier:
NCT02973282
First received: November 22, 2016
Last updated: April 13, 2017
Last verified: April 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in diagnosis of pneumonia and other respiratory conditions (bronchiolitis, asthma/reactive airway disease, croup, upper or lower respiratory tract infections) in infants and children. Patient's cough sounds will be recorded using a smartphone and analysed using the ResAppDx software. The ResAppDx diagnosis will be compared to radiologic diagnosis and/or clinical diagnosis. The ResAppDx diagnosis will not be provided to the clinician or patient.
| Condition | Intervention |
|---|---|
| Pneumonia Bronchiolitis Asthma Croup Upper Respiratory Tract Infection Lower Respiratory Tract Infection Reactive Airway Disease | Other: Recording of Infants and Children's Cough Sounds |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds |
Resource links provided by NLM:
Further study details as provided by ResApp Health Limited:
Primary Outcome Measures:
- Diagnosis of pneumonia [ Time Frame: 6 months ]
Positive percent agreement and negative percent agreement to diagnose and rule out pneumonia as compared with a radiologic diagnosis.
Positive percent agreement and negative percent agreement to diagnose and rule out pneumonia as compared with a clinical diagnosis.
Secondary Outcome Measures:
- Diagnosis of other childhood respiratory diseases [ Time Frame: 6 months ]Positive percent agreement and negative percent agreement to diagnose and rule out: lower respiratory tract involvement, bronchiolitis, asthma/reactive airway disease, upper respiratory tract infection and/or croup, as compared with a clinical diagnosis.
| Estimated Enrollment: | 1111 |
| Study Start Date: | December 2016 |
| Estimated Study Completion Date: | June 2017 |
| Estimated Primary Completion Date: | June 2017 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Other: Recording of Infants and Children's Cough Sounds
Smartphone recordings of the cough sounds of infants and children presenting to a participating site with signs or symptoms of respiratory disease
Eligibility| Ages Eligible for Study: | up to 12 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients with signs or symptoms of respiratory disease presenting to participating Emergency Departments, Urgent Care Clinics, Primary Care Clinics
Criteria
Inclusion Criteria:
- Infant or child aged 29 days - 12 years
- Presenting to the study site with signs or symptoms of respiratory disease including cough, wheezing, stridor, chest in-drawing/retractions, difficulty breathing, fast breathing, abnormal lung sounds on exam, cyanosis/hypoxemia.
- Coughing spontaneously or able to cough voluntarily
Exclusion Criteria:
- Lack of a signed consent form from parent or legal guardian
- Lack of signed assent form for children aged 7 years or older who, in the opinion of the investigator, is able to provide assent based on their age, maturity or psychological state.
- Need for mechanical ventilatory support (including invasive, continuous positive airway pressure, or bilevel positive airway pressure) or high flow nasal cannula
- Any medical contraindication to voluntary cough, including (only enrolled if coughing spontaneously): severe respiratory distress, history of pneumothorax, eye/chest/abdominal surgery in past 3 months, hemoptysis in the past month, or too medically unstable to participate in study per treating clinician.
- Subject previously enrolled
- Tracheostomy present or tube placed
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT02973282
Please refer to this study by its ClinicalTrials.gov identifier: NCT02973282
Contacts
| Contact: Kay Taylor, PhD | +617 3724 0035 | kay@resapphealth.com.au |
Locations
| United States, Massachusetts | |
| Massachusetts General Hospital | Recruiting |
| Boston, Massachusetts, United States, 02114 | |
| Contact: Peter P Moschovis, MD MPH 617-643-9687 pmoschovis@mgh.harvard.edu | |
| Principal Investigator: Peter P Moschovis, MD MPH | |
| United States, Ohio | |
| Cleveland Clinic Children's | Recruiting |
| Cleveland, Ohio, United States, 44195 | |
| Contact: John C Carl, MD 216-444-3916 CARLJ@ccf.org | |
| Principal Investigator: John C Carl, MD | |
| United States, Texas | |
| Texas Children's Hospital | Recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: Esther M Sampayo, MD MPH 832-824-6512 sampayo@bcm.edu | |
| Principal Investigator: Esther M Sampayo, MD MPH | |
Sponsors and Collaborators
ResApp Health Limited
Massachusetts General Hospital
The Cleveland Clinic
Texas Children's Hospital
Investigators
| Principal Investigator: | Peter P Moschovis, MD, MPH | Massachusetts General Hospital |
More Information
| Responsible Party: | ResApp Health Limited |
| ClinicalTrials.gov Identifier: | NCT02973282 History of Changes |
| Other Study ID Numbers: |
16001 |
| Study First Received: | November 22, 2016 |
| Last Updated: | April 13, 2017 |
| Individual Participant Data | |
| Plan to Share IPD: | No |
Additional relevant MeSH terms:
|
Infection Communicable Diseases Pneumonia Bronchiolitis Respiratory Tract Infections Respiration Disorders |
Respiratory Tract Diseases Bronchial Hyperreactivity Lung Diseases Bronchitis Bronchial Diseases Lung Diseases, Obstructive |
ClinicalTrials.gov processed this record on June 23, 2017